Point72 Asset Management
ELVN icon

Point72 Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Point72 Asset Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$27.1M Buy
2025
Q1 		$2.75M Buy
2023
Q2 		– Sell
2023
Q1 		$16.3K Buy